Yoga may ease depression and anxiety during cancer transplants
NCT ID NCT05681026
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a yoga program designed to fit different cultures can help cancer patients who are getting a stem cell transplant. About 60 adults in India, Tanzania, and the United States will take part in up to 12 yoga sessions before and during their hospital stay. Researchers will measure changes in mood, anxiety, and quality of life through questionnaires and interviews.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- yoga therapy sessions
- What this could lead to
- If successful, this could provide a simple, drug-free way to help cancer patients feel better emotionally and physically during a difficult transplant hospital stay.
- What could go wrong
- This is a small, early-stage pilot study with only 60 participants, so results may not apply to everyone. Yoga may not significantly reduce symptoms for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2023
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH; 2. Age 18 or older; 3. English, Hindi, or Swahili speaking; 4. Able to sign a written informed consent and be willing to follow protocol requirements. Exclusion Criteria: * Extreme mobility issues that preclude participating in the YT; * Major thought disorders such as schizophrenia or uncontrolled bipolar disorder; * HCT comorbidity score of 3 or higher, excluding cancer diagnoses
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites in 3 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Muhimbili National Hospital
RECRUITINGDar es Salaam, Tanzania
-
Swami Vivekananda Yoga Anusandhana Samsthana
RECRUITINGGiddenahalli, Karnataka, 560105, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?